Ghost Tree Capital’s Clovis Oncology, Inc. CLVS Stock Holding History

Ghost Tree Capital’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-75,000	Closed	-$3.96M	–	65
2018 Q1	$3.96M	Sell	75,000 -25,000	-25%	-$1.46M	0.8%	40
2017 Q4	$6.8M	Buy	+100,000	New	+$6.99M	1.59%	24
2017 Q2	–	Sell	-200,000	Closed	-$12.2M	–	81
2017 Q1	$12.7M	Sell	200,000 -20,000	-9%	-$1.22M	2.37%	7
2016 Q4	$9.77M	Sell	220,000 -280,000	-56%	-$9.85M	2.35%	12
2016 Q3	$18M	Buy	500,000 +50,000	+11%	+$1.07M	2.92%	7
2016 Q2	$6.17M	Buy	450,000 +431,500	+2,332%	+$6.31M	1.78%	20
2016 Q1	$355K	Buy	+18,500	New	+$392K	0.2%	49
2014 Q4	–	Sell	-65,000	Closed	-$2.95M	–	86
2014 Q3	$2.95M	Buy	+65,000	New	+$2.72M	1.6%	28
2014 Q1	–	Sell	-30,000	Closed	-$1.81M	–	82
2013 Q4	$1.81M	Buy	+30,000	New	+$1.63M	1.11%	35

Other funds holding CLVS

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Franklin Resources

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return